SITO is a high-tech enterprise focused on steroidal biomedicine-related R&D, production and sales, covering 200,000 square meters including a 2,200-square-meter biotechnology R&D center and an R&D team of 42 technicians. Its main products, using newly developed biological methods, include Androstenedione (4-AD), 1,4-Androstadiene-3,17-Dione (ADD), 17α-Hydroxyprogesterone and 17α-Acetoxyprogesterone.

暂无评论。
留下您的评分和评论